In the post-pandemic era, mental health has transitioned from a niche concern to a global health priority. The anxiety relief supplements market is currently witnessing an unprecedented CAGR of 8.5%, driven by a professional workforce facing burnout, students seeking focus, and an aging population prioritizing neuroprotection.
Technological integration is at the heart of this growth. Modern consumers are no longer satisfied with generic vitamins; they demand 🧪 Biochemical bioavailability and Synergistic formulations. Global enterprises are shifting focus toward adaptogens like Ashwagandha and L-Theanine, which balance cortisol levels without the sedative effects of traditional pharmaceuticals.
The industry is moving toward "Clean Label" transparency. As a leading China OEM/ODM Anxiety Relief Supplements Supplier, we observe a surge in demand for non-GMO, gluten-free, and vegan-certified products. The convergence of AI and Nutrition—"Nootropics"—is the latest trend, where supplements are designed to optimize cognitive performance alongside stress relief.
Localization Strategy: Procurement teams in North America are looking for rapid-absorption sublingual tablets, while European markets favor sustainable herbal extracts with historical backing like Saffron and Rhodiola.
Located in Shandong, Zhejiang, and Hebei with multi-regional capability.
GMP, ISO, FAMI-QS, KOSHER, and HALAL certified facilities.
Specialized in API, vitamin synthesis, and herbal extract isolation.
Strategic marketing partners in Mumbai and Dubai for seamless logistics.
Xian QLU Health Pharmaceutical Technology Co., Ltd. is engaged in the development, production, and marketing of pharmaceutical products, food ingredients, vitamins, intermediates, and chemicals. Based in the historic hub of Xian, China, we leverage centuries of botanical knowledge combined with modern AI-driven manufacturing.
Our spirit is characterized by ⚡ Flexibility and Adaptability. In the ever-changing pharmaceutical industry, we embrace emerging technologies to meet the evolving needs of patients and healthcare providers globally. From 2012 to our 2024 expansion, we have focused on becoming a one-stop-shop for global distributors.
Global enterprises today require more than just a manufacturer; they need a partner who understands regulatory landscapes. Whether you are a brand on Amazon/Temu or a regional healthcare chain, our ODM services provide:
2012.2: Focus on pharmaceutical products and vitamins.
2015.12: Expanding to global marketing of APIs and ingredients.
2023.9: Full-scale production integration for global supply chains.
2024.4: Devoted to advanced development of APIs and hi-tech chemicals.
QLU Health
